Dr Ridhurkar is a Biopharmaceutical Subject Matter Expert based in Barcelona, Spain. He boasts over 17 years of invaluable scientific leadership and management expertise in the complex formulation development and manufacturing of small and biological compounds. Renowned for his proficiency in steering projects encompassing Biosimilar, Protein and Peptides, Proprietary and Generic drugs, including 505b2, Hybrid, Complex, Specialty, and Branded formulations, he has significantly impacted Pharma-Biotech companies worldwide.

He is celebrated for leveraging cutting-edge technologies, such as nanotechnology, lyposomal drug delivery, long acting injectables, pre-filled syringes, injectable drug-devices, and parenteral systems for biosimilars including mAb Vaccines. Additionaly he has hands on experience on pulmonary drug delivery, hot melt extrusion, 3D printing, continuous manufacturing, modified release, and cyclodextrin complexation, to advance drug development and delivery mechanisms. With a stellar academic background, Dr Ridhurkar earned his M. Pharm and PhD in Pharmaceutical technology from the prestigious IIT, Varanasi, India. He has authored over ten peer-reviewed papers in esteemed journals and holds nine patents, showcasing his innovative prowess.

Beyond his expertise in drug product and devices development, he actively contributes to the global pharmaceutical community. He holds positions on the editorial boards of reputable journals and actively engages with pharmaceutical bodies in Spain, Hungary, India and the American Association of Pharmaceutical Scientists, significantly contributing to the advancement of the Pharma-Biotech sector. He serves on the program advisory committee for prestigious events such as the Pharma Connect Congress in Hungary,R&Y, and the Why Summit in Germany. Dr Ridhurkar’s seminars and presentations at scientific conferences are highly anticipated for their enlightening insights and groundbreaking research contributions, garnering significant attention from participants.